Maplight Therapeutics, Inc. · NASDAQ:MPLT
Maplight Therapeutics, Inc. shareholders
As of Jun 30, 2026, 101 institutions reported holding Maplight Therapeutics, Inc., 61.9% of its shares. Largest: T. Rowe Price, Novo Holdings A/S and Fcpm III Services B.V. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Maplight Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| T. Rowe Price | 4.2M | 9.9% | +1.29M | Aug 14, 2026 |
| Novo Holdings A/S | 3.69M | 8.7% | no change | Aug 14, 2026 |
| Fcpm III Services B.V. | 3.23M | 7.6% | no change | Aug 14, 2026 |
| Goldman Sachs | 1.95M | 4.6% | −46,561 | Aug 14, 2026 |
| BlackRock | 1.03M | 2.4% | −315K | Aug 7, 2026 |
| Vanguard | 1.01M | 2.4% | +40,391 | Aug 13, 2026 |
| Nan Fung Group Holdings Ltd | 971K | 2.3% | no change | Aug 13, 2026 |
| 5AM Venture Management, LLC | 950K | 2.2% | no change | Aug 14, 2026 |
| Sanofi | 912K | 2.1% | no change | Jul 28, 2026 |
| State Street | 852K | 2.0% | +513K | Aug 7, 2026 |